| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/23/2002 | US6423342 Fast dispersing composition with selegiline |
| 07/23/2002 | US6423341 A beta -lactam antibiotic-containing tablet which comprises a beta-lactam antibiotic such as cefixime or cefdinir, a low-substituted hydroxypropylcellulose and/or crosslinked polyvinylpyrrolidone as disintegrator and a binder |
| 07/23/2002 | US6423340 Gastrointestinal disorders, crohn's colitis |
| 07/23/2002 | US6423339 Liquisolid systems and methods of preparing same |
| 07/23/2002 | US6423338 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 07/23/2002 | US6423336 Chewing gums and method of manufacturing the same |
| 07/23/2002 | US6423323 Foam skin cream, uses of the foam skin protection cream and a process for its preparation |
| 07/23/2002 | US6423312 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 07/23/2002 | US6423307 For use in the topical treatment of mucosal affections |
| 07/23/2002 | US6423300 Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 07/23/2002 | US6423299 Aerosols for bacterial infections |
| 07/23/2002 | US6423298 Pharmaceutical formulations for aerosols with two or more active substances |
| 07/23/2002 | US6423297 Containers and aerosols with propellents |
| 07/23/2002 | US6423256 Process for producing solid dosage forms |
| 07/23/2002 | US6423039 Synchronizing of animal oestrus and intra vaginal devices useful therein |
| 07/23/2002 | CA2215317C Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 07/23/2002 | CA2126685C Process for the production of microcapsules |
| 07/23/2002 | CA2101556C Growth factor containing matrix for the treatment of cartilage lesions |
| 07/23/2002 | CA2097827C Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/23/2002 | CA2087723C Treatment with flurbiprofen of pain and inflammation in mammals |
| 07/23/2002 | CA2060560C Method for insuring adequate intracellular glutathione in tissue |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055559A1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants |
| 07/18/2002 | WO2002055506A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop |
| 07/18/2002 | WO2002055185A2 Block copolymers for multifunctional self-assembled systems |
| 07/18/2002 | WO2002055136A2 Intrasvascular drug delivery device and use therefor |
| 07/18/2002 | WO2002055101A2 Storage stable powder compositions of interleukin-4 receptor |
| 07/18/2002 | WO2002055093A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 07/18/2002 | WO2002055076A1 Cyclodextrin-containing pharmaceutical preparation |
| 07/18/2002 | WO2002055074A1 Preventives or remedies for arthritis |
| 07/18/2002 | WO2002055073A1 Preventives for arthritis |
| 07/18/2002 | WO2002055070A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy |
| 07/18/2002 | WO2002055067A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | WO2002055066A1 Fumaric acid derivatives as nf-kappa-b inhibitors |
| 07/18/2002 | WO2002055062A2 Pharmaceutical tablet comprising paroxetine mesylate |
| 07/18/2002 | WO2002055061A2 Method of producing porous tablets with improved dissolution properties |
| 07/18/2002 | WO2002055060A2 Skin product having micro-spheres, and processes for the production thereof |
| 07/18/2002 | WO2002055059A2 Method for preparing submicron particle suspensions |
| 07/18/2002 | WO2002055058A2 Flexible microchip devices for ophthalmic and other applications |
| 07/18/2002 | WO2002055057A2 Treatment of asthma and other lung conditions |
| 07/18/2002 | WO2002055056A2 Local use of essential oils for treating herpes labialis |
| 07/18/2002 | WO2002055023A2 Therapeutic film forming composition and treatment system |
| 07/18/2002 | WO2002055020A2 Topical testosterone formulations and associated methods |
| 07/18/2002 | WO2002055011A2 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 07/18/2002 | WO2002055009A1 Spaced drug delivery system |
| 07/18/2002 | WO2002054997A1 Devices for local and systemic delivery of active substances and methods of manufacturing thereof |
| 07/18/2002 | WO2002054996A2 Terazosin transdermal device and methods |
| 07/18/2002 | WO2002054868A2 Pulmonary delivery of polyene antifungal agents |
| 07/18/2002 | WO2002041829A3 Oral nanosphere delivery |
| 07/18/2002 | WO2002039978A8 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 07/18/2002 | WO2002038134A3 Multilayered supporting construction for plaster systems containing an active ingredient |
| 07/18/2002 | WO2002036600A3 Derivatised carbohydrates and their use in solid delivery systems |
| 07/18/2002 | WO2002034206A3 Felodipine transdermal device and methods |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002030377A3 Product for cleaning teeth and/or the mouth |
| 07/18/2002 | WO2002024184A3 Mechanically stable dosage forms containing ubiquinones |
| 07/18/2002 | WO2002022109A3 Patch comprising diclofenac |
| 07/18/2002 | WO2002015937A3 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 07/18/2002 | WO2002013856A3 W/o emulsion adjuvant compositions for vaccines |
| 07/18/2002 | WO2002003989A3 Use of substituted indole compounds for treating sphincter incontinence |
| 07/18/2002 | WO2002003800A9 Device and method for photoactivated drug therapy |
| 07/18/2002 | WO2002001962A3 A positive hydration method of preparing confectionery and the resulting product |
| 07/18/2002 | WO2001091902A3 Methods and devices for sealing microchip reservoir devices |
| 07/18/2002 | WO2001087322A3 Peptide pharmaceutical formulations |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001084565A3 Method and apparatus for manufacture of magnetizable microparticles |
| 07/18/2002 | WO2001056547A3 Preparation of aqueous clear solution dosage forms with bile acids |
| 07/18/2002 | WO2001053320A9 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 07/18/2002 | WO2001045679A3 Use of chemotherapeutic agents for topical treatment |
| 07/18/2002 | WO2001032217A3 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 07/18/2002 | WO2001006991A9 Oil-in-water emulsion with improved stability |
| 07/18/2002 | US20020095138 Pivoting joint infusion assembly |
| 07/18/2002 | US20020095108 Photoreduction method for hemoglobin-visicle |
| 07/18/2002 | US20020095025 Isolation and uses of caveolae |
| 07/18/2002 | US20020094996 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 07/18/2002 | US20020094992 Administering growth hormone secretagogue which is 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a, 4,6,7-hexahydro-pyrazolo(4,3-c)pyridin-5-yl)1-(R)-benzyloxymet hyl-2-oxo-ethyl)-isobutyramide, salt or prodrug |
| 07/18/2002 | US20020094985 Differential delivery of nitric oxide |
| 07/18/2002 | US20020094971 Hyperglucemic, antidiabetic agents comprising a granulated starch having a reduced surface available for enzymatic degradation to delay production of reducing sugars; oral time-release agents; surgical patients; athletes |
| 07/18/2002 | US20020094959 By injecting a biocompatible solution, with a given intrinsic viscosity, similar to a fatty acid mixture normally present in a healthy fat pad; treating heel pain |
| 07/18/2002 | US20020094948 To treat anemias or hemodialysis patients; individual dosage forms |
| 07/18/2002 | US20020094347 A neuro-active molecule, other than dopamine, within a microsphere comprising a biocomatible polymer having kinetic characteristics that may be manipulated to allow for the permeation of drug through polymer at controlled rate |
| 07/18/2002 | US20020094346 Administering dose of anti-atherogenic, anti-diarrheal, digestion, dissolution, absorption promoting and/or gastrointestinal transit slowing composition comprising an active lipid |
| 07/18/2002 | US20020094345 For treatment of allergic diseases and/or disorders; composition does not contain a leukotriene antagonist |
| 07/18/2002 | US20020094344 Transmembrane permeation induced by alcohols |
| 07/18/2002 | US20020094343 Topical dermal anaesthetic |
| 07/18/2002 | US20020094330 Lytic enzyme produced by bacteria being infected with a bacteriophage specific for said bacteria and carrier for delivering enzyme to eye |
| 07/18/2002 | US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 07/18/2002 | US20020094324 Gene therapy for restenosis using an adenoviral vector |
| 07/18/2002 | US20020094319 Lytic enzyme produced by bacteria infected with a bacteriophage specific for that bacteria and a carrier; for treating bacterial infections of the mouth or teeth; anticaries agent |
| 07/18/2002 | US20020094318 Dispersible dry powder of a therapeutic agent such as insulin with an aerogel particle which is soluble in human pulmonary surfactant, such as sugars and carbohydrates |
| 07/18/2002 | US20020092470 Article comprising a diffuser with flow control features |
| 07/18/2002 | DE10100809A1 Verwendung von ätherischen Ölen zur topischen Behandlung von viralen Hauterkrankungen Use of essential oils for topical treatment of viral skin diseases |
| 07/18/2002 | CA2725833A1 Spaced drug delivery system |
| 07/18/2002 | CA2436814A1 Intravascular drug delivery device and use therefor |
| 07/18/2002 | CA2434409A1 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 07/18/2002 | CA2434077A1 Cyclodextrin preparations |
| 07/18/2002 | CA2433713A1 Preventives for arthritis |
| 07/18/2002 | CA2432350A1 Method for inhibiting the expression of a target gene |
| 07/18/2002 | CA2432319A1 Pulmonary delivery of polyene antifungal agents |